These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32742470)

  • 1. Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
    Han W; Xu J; Shen GL
    J Cancer; 2020; 11(17):5245-5256. PubMed ID: 32742470
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
    Wu S; Zang Q; Dai B
    Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
    Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
    BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma.
    Han W; Shen GL
    Int Immunopharmacol; 2020 Nov; 88():106958. PubMed ID: 33182068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma.
    Wu S; Liang Y; Zang Q; Xing Z; Yin P; Sun R; Dai B
    Appl Bionics Biomech; 2022; 2022():5160748. PubMed ID: 35607429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma.
    Yang H; Che D; Gu Y; Cao D
    Front Genet; 2022; 13():940306. PubMed ID: 36110204
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
    Jiang Y; Zhang C; Zhang J; Han D; Shi X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.
    Jiang L; Yang Y; Liu F; Ma M; Gao J; Sun L; Chen Y; Shen Z; Wu D
    Front Cell Dev Biol; 2022; 10():859958. PubMed ID: 35399535
    [No Abstract]   [Full Text] [Related]  

  • 11. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
    Sun X; Zhang J; Xiao C; Ge Z
    BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
    Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
    Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma.
    Zhao S; Wen S; Liu H; Zhou Z; Liu Y; Zhong J; Xie J
    Front Surg; 2022; 9():917776. PubMed ID: 36034394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
    J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma.
    Wang Y; Zhang H
    Front Mol Biosci; 2022; 9():805887. PubMed ID: 35300113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.